Advisory Committee

---

Larta Institute would like to extend a special thanks to the 2008 Advisory Committee.

David Bowser, Vice President, Technology Transfer & Academic Relations, Johnson and Johnson

G. Steven Burrill, CEO, Burrill & Company

Rainer Fuchs, Vice President, Biogen Idec Innovation Incubator, Biogen Idec, Inc.

Phil Giesler, Managing Director, Physic Ventures

Paul M. Grand, Director, RCT BioVentures, Research Corporation Technologies, Inc.

Robert Gruetzmacher, Director of Technology Commercialization, DuPont Center for Collaborative Research and Education

Bruce Halpryn, Sr. Director, New Business Development & Global Leader, Technical Due Dillegence, P&G Pharmaceuticals

Kinney Horn, Business Development, Genentech

Raymond M. Jordt, Senior Associate Lilly Accelerators

Don A. Madren, RPh, MBA, Associate Director, Strategic Alliances, Pfizer

Graeme R. Martin, CEO, Takeda Research Investment Inc.

Lloyd Mencinger, Vice President New Market Development/Strategic Planning, Boston Scientific

Monica Morse, Managing Director, Cargill Ventures

Bruce Pratt, Vice President, Science Development, Genzyme Corporation

Wayne J. Puglia, Senior Director-Investment Strategy, Kraft Open Innovation

Kimberly Rogers, VP, Technology Assessment, Allergan

Dr. James M. Schaeffer, Executive Director of Worldwide Licensing and External Research, Merck & Co., Inc.

Alex Suh, Managing Director, California Technology Ventures

Ben Verwer, Manager, Corporate Strategy & Development, BD Ventures

Michael Wynblatt, Chief Technology Officer, Siemens TTB